Company Filing History:
1 out of 2,198 
1 out of 676 
Years Active: 1999
Title: Maxine Gowen: Innovator in Cathepsin K Research
Introduction: Maxine Gowen, located in Valley Forge, PA, is a distinguished inventor with a significant contribution to the field of biochemistry through her patented work on Cathepsin K. With numerous advancements in the understanding of polypeptides and their applications, her research has paved the way for innovations in diagnostics and therapeutic methods.
Latest Patents: Maxine Gowen holds one notable patent related to Cathepsin K. This invention involves cathepsin K polypeptides, polynucleotides that encode these polypeptides, and methods for producing the polypeptides, primarily through the expression of the polynucleotides. Additionally, the patent covers agonists and antagonists of the polypeptides and provides methods for utilizing such polynucleotides, polypeptides, and their derivatives for research, diagnostic, and clinical applications.
Career Highlights: Maxine Gowen's career boasts significant stints at leading companies including SmithKline Beecham Corporation and Human Genome Sciences, Inc. During her time at these organizations, she played a pivotal role in advancing proprietary research that has significant implications for the medical field.
Collaborations: Throughout her career, Maxine has had the opportunity to collaborate with esteemed colleagues, including Mark D. Adams and Judith A. Blake. Their collective efforts have contributed to breakthroughs in biochemistry and have enhanced the understanding of various polypeptide functions.
Conclusion: Maxine Gowen's innovative contributions to Cathepsin K research highlight her impact in the fields of molecular biology and therapeutics. With her singular patent, she continues to inspire ongoing research and development aimed at tackling complex medical challenges. Her work remains highly relevant in both the academic and commercial spheres, cementing her legacy as a proficient inventor.